Eli Lilly and (LLY) Revenue — Quarter Ended Jun 30, 2025
Revenue increased both sequentially and year over year. The current quarter’s revenue was higher than the preceding quarter and also exceeded the year-ago figure.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue increased both sequentially and year over year. The current quarter’s revenue was higher than the preceding quarter and also exceeded the year-ago figure.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15.6B
Revenue reported for this quarter.
Quarter-over-quarter
+22.2%
Change from the immediately preceding quarter.
Year-over-year
+37.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$53.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $11.4B | +20.4% |
| Dec 31, 2024 | $13.5B | +44.7% |
| Mar 31, 2025 | $12.7B | +45.2% |
| Jun 30, 2025 | $15.6B | +37.6% |
Revenue performance
The reported revenue direction is positive, with growth from the prior quarter and from a year earlier.
Quarterly comparison
Sequentially, revenue increased from the previous quarter. On a year-over-year basis, revenue was higher than the same quarter last year.
What to watch
Future revenue trajectories relative to these benchmarks will be an important measure.